Latest News
Web Date: January 10, 2017

Perlara signs pacts with Grace Science and Wylder Nation Foundation

Deals mark quirky biotech’s first direct partnerships with advocacy groups
Department: Business
Keywords: rare disease, Perlara, Grace Science, biotech

Building on its unusual business model, Perlara has secured its first two deals with patient advocacy groups looking to directly fund discovery of drugs for rare diseases. Grace Science Foundation, focused on finding a cure for Ngly1 deficiency, and the Wylder Nation Foundation, which seeks treatments for acid sphingomyelinase deficiency (ASD), will both back early-stage research at the biotech firm.

Each family-run group has signed up for what Perlara calls a PerlQuest, a tailored research . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society